(Q41872131)

13 October 2017

A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed acute myeloid leukaemia (English)

1 reference

13 October 2017

1 reference

1 reference

13 October 2017

Hagop M Kantarjian

1 reference

13 October 2017

Stefan Faderl

1 reference

13 October 2017

Farhad Ravandi

1 reference

13 October 2017

Jorge E Cortes

1 reference

13 October 2017

Frederick R. Appelbaum

series ordinal

object named as

Frederick R Appelbaum

1 reference

13 October 2017

Megan Othus

1 reference

13 October 2017

Stephen H Petersdorf

1 reference

13 October 2017

Cheryl L Willman

1 reference

13 October 2017

Alan F List

1 reference

13 October 2017

Derek L Stirewalt

1 reference

13 October 2017

Pamela S Becker

1 reference

13 October 2017

Paul C Hendrie

1 reference

13 October 2017

John E Godwin

1 reference

13 October 2017

Fabiana Ostronoff

1 reference

13 October 2017

Elihu H Estey

1 reference

13 October 2017

Soheil Meshinchi

1 reference

13 October 2017

John M Pagel

1 reference

13 October 2017

Sherry A Pierce

series ordinal

1 reference

13 October 2017

Ravinder K Sandhu

series ordinal

1 reference

13 October 2017

language of work or name

English

0 references

publication date

6 July 2013

1 reference

British Journal of Haematology

13 October 2017

1 reference

13 October 2017

163

1 reference

13 October 2017

1 reference

13 October 2017

130-132

1 reference

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128010

Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500)

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23829510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/BJH.12450

1 reference

13 October 2017

1 reference

13 October 2017

PubMed publication ID

23829510

1 reference